243 results
Showing 1–20 · 0.40 seconds · RSS
BMJ Oncology
Scopus
ISSN 2752-7948 · BMJ Publishing Group · 243 articles in the index
-
Journal Article Full text
Bladder-sparing strategies for non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure: a systematic review
Objective Non-muscle-invasive bladder cancer (NMIBC) is typically managed with transurethral resection and intravesical instillation therapy. For patients with high-risk NMIBC after failure of bacillus Calmette–Guérin (BCG) therapy, radical cystectomy and urinary diversion are the standard of care…
Also available at: DOAJ
-
Journal Article Full text
Human and financial consequences of herding in oncology drug development: clinical trials of TIGIT inhibitors
Objectives To illustrate and quantitate how herding in oncology drug development (five or more biopharmaceutical companies competing to develop modulators of an identical target) amplifies the number of patients enrolled in clinical trials of experimental drugs, and to estimate the cost of…
Also available at: DOAJ
-
Journal Article Full text
Impact of immunotherapy and small molecule cancer therapy on fertility: a narrative review of current evidence, mechanisms and future directions
With increasing cancer incidence among individuals of reproductive age, preserving fertility has become a critical aspect of cancer care. This narrative review explores the impact of contemporary cancer therapies, including immunotherapies and targeted agents, on reproductive health, highlighting…
Also available at: DOAJ
-
Journal Article
Deficient mismatch repair/microsatellite instability-high colorectal cancer: current treatment paradigms, limitations and future perspectives
The treatment paradigm for deficient mismatch repair (dMMR) colorectal cancer (CRC) has evolved substantially in recent years. Universal mismatch repair testing and broad use of next-generation sequencing have increased the detection of dMMR tumours, which exhibit microsatellite instability-high…
-
Journal Article
First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours
Objective W0180 is a humanised IgG1κ antagonistic monoclonal antibody against the V domain-containing immunoglobulin suppressor of T-cell activation (VISTA) designed to enhance antitumour activities by inhibiting the immunosuppressive role of VISTA in myeloid cells and T cells in solid…
-
Journal Article
Cancer care in wartime Ukraine: disruption, resilience and recovery
Before Russia’s full-scale invasion in February 2022, Ukraine maintained a well-functioning oncology system, supported by universal health coverage and expanding access to advanced diagnostics and clinical trials. The war caused profound disruptions across all aspects of cancer care—diagnostics…
-
Journal Article
SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer
Background Many patients with non-small cell lung cancer (NSCLC) have tumours that are either refractory or develop resistance following an initial response to anti-programmed cell death protein (ligand)-1 (PD-(L)1)-based treatment, resulting in limited treatment options. SAFFRON-301 evaluated…
-
Journal Article
Incidence of new-onset depression after colorectal cancer diagnosis and associated mortality: a population-based cohort study
Objectives To examine the incidence of and factors associated with new-onset depression following colorectal cancer (CRC) diagnosis and its association with all-cause and CRC-specific mortality.Design Population-based retrospective cohort study using linked administrative health databases.Setting…
-
Journal Article
Active surveillance for a small low-risk papillary thyroid cancer: a 10-year prospective, observational study in an Italian tertiary care centre
Objective To evaluate the long-term safety and feasibility of active surveillance (AS) for Italian patients with low-risk papillary thyroid microcarcinoma (mPTC) and to analyse trends in patient enrolment and factors associated with discontinuation of surveillance. This study represents the first…
-
Journal Article
Cytotoxic T-cell exhaustion analyses by in situ single-cell immunofluorescence in relation to colorectal cancer patient age, tissue bacteria and mortality
Objectives We hypothesised that cytotoxic T-cell exhaustion status in colorectal cancer (CRC) microenvironment relates to age of diagnosis (eg, early-onset CRC), pathogenic bacteria and clinical outcomes.Design Population-based prospective cohort study using the prospective cohort incident-tumour…
-
Journal Article
Screen-and-treat: a sustainable solution for cervical cancer elimination in low and middle income countries
Cervical cancer is a largely preventable disease, yet over 90% of its global mortality occurs in low and middle income countries(LMICs), reflecting profound inequities in access to screening and treatment. Traditional multivisit cervical cancer prevention models have been inadequate in these…
-
Journal Article
Bayesian networks as prognostic models in oncology: a systematic review and recommendations for clinical practice
Objectives In the last decades, artificial intelligence has made tremendous steps in supporting decision-making in healthcare. Bayesian networks (BNs) have emerged as powerful tools for probabilistic modelling and offer important advantages compared with regression-based models. This systematic…
-
Journal Article
Investigating the determinants of immunotherapy response in the primary tumour of clear cell renal cell carcinoma (RCC)
Objective Immune checkpoint inhibitors (ICIs) have demonstrated durable clinical benefit in a subset of patients with metastatic renal cell carcinoma (RCC), yet the molecular features that govern therapeutic response within the primary tumour remain poorly defined. This is of particular importance…